Wambolt & Associates’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-2,251
Closed -$374K 242
2022
Q3
$374K Hold
2,251
0.16% 167
2022
Q2
$464K Sell
2,251
-29
-1% -$6.54K 0.19% 154
2022
Q1
$565K Sell
2,280
-108
-5% -$25K 0.21% 146
2021
Q4
$581K Sell
2,388
-5
-0.2% -$1.14K 0.21% 142
2021
Q3
$497K Hold
2,393
0.2% 147
2021
Q2
$500K Buy
2,393
+52
+2% +$10.5K 0.21% 147
2021
Q1
$453K Buy
2,341
+156
+7% +$28.9K 0.24% 141
2020
Q4
$414K Hold
2,185
0.25% 131
2020
Q3
$385K Hold
2,185
0.29% 122
2020
Q2
$335K Buy
2,185
+369
+20% +$56.2K 0.26% 135
2020
Q1
$254K Buy
+1,816
New +$272K 0.26% 127

Other funds holding STE

Wambolt & Associates's STE Position: Q4 2022 in Review

Wambolt & Associates sold out of Steris (STE) in Q4 2022, closing a stake of 2,251 shares — an estimated $374K sold.

Wambolt & Associates first reported a position in STE in Q1 2020 and held it in 11 quarters. The position peaked at $581K in Q4 2021. 648 funds tracked by Wall St. Rank hold STE as of Q4 2022.

  • Wambolt & Associates reported no remaining Steris position as of Q4 2022 after selling out during the quarter.
  • Wambolt & Associates sold 2,251 Steris shares in Q4 2022, an estimated $374K.
  • Wambolt & Associates first reported a position in Steris in Q1 2020 and held it in 11 quarters.
  • Wambolt & Associates's Steris position peaked at $581K in Q4 2021.
  • 648 funds tracked by Wall St. Rank held Steris as of Q4 2022.

Based on Wambolt & Associates's 13F filing for Q4 2022, filed 1 Feb 2023.